Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Roche posts positive PhII results for bispecific antibody eye drug, joining Novartis in rivalry with Eylea
Roche posts positive PhII results for bispecific antibody eye drug, joining Novartis in rivalry with Eylea
Roche posts positive PhII results for bispecific antibody eye drug, joining Novartis in rivalry with Eylea
Submitted by
admin
on February 12, 2018 - 9:49am
Source:
Endpoints
News Tags:
Roche
bispecific antibodies
RG7716
Novartis
Eylea
Headline:
Roche posts positive PhII results for bispecific antibody eye drug, joining Novartis in rivalry with Eylea
Do Not Allow Advertisers to Use My Personal information
